These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8610771

  • 1. Multivariate survival analysis of clinicopathologic features in surgical stage I endometrioid carcinoma including analysis of HER-2/neu expression.
    Nazeer T, Ballouk F, Malfetano JH, Figge H, Ambros RA.
    Am J Obstet Gynecol; 1995 Dec; 173(6):1829-34. PubMed ID: 8610771
    [Abstract] [Full Text] [Related]

  • 2. Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer.
    Lukes AS, Kohler MF, Pieper CF, Kerns BJ, Bentley R, Rodriguez GC, Soper JT, Clarke-Pearson DL, Bast RC, Berchuck A.
    Cancer; 1994 May 01; 73(9):2380-5. PubMed ID: 7909491
    [Abstract] [Full Text] [Related]

  • 3. Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.
    Riben MW, Malfetano JH, Nazeer T, Muraca PJ, Ambros RA, Ross JS.
    Mod Pathol; 1997 Aug 01; 10(8):823-31. PubMed ID: 9267826
    [Abstract] [Full Text] [Related]

  • 4. P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression.
    Coronado PJ, Vidart JA, Lopez-asenjo JA, Fasero M, Furio-bacete V, Magrina J, Escudero M.
    Eur J Obstet Gynecol Reprod Biol; 2001 Sep 01; 98(1):103-8. PubMed ID: 11516808
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemically detected HER-2/neu-expression and prognosis in endometrial carcinoma.
    Backe J, Gassel AM, Krebs S, Müller T, Caffier H.
    Arch Gynecol Obstet; 1997 Sep 01; 259(4):189-95. PubMed ID: 9271838
    [Abstract] [Full Text] [Related]

  • 6. HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma.
    Pisani AL, Barbuto DA, Chen D, Ramos L, Lagasse LD, Karlan BY.
    Obstet Gynecol; 1995 May 01; 85(5 Pt 1):729-34. PubMed ID: 7724103
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer.
    Kohlberger P, Loesch A, Koelbl H, Breitenecker G, Kainz C, Gitsch G.
    Cancer Lett; 1996 Jan 02; 98(2):151-5. PubMed ID: 8556702
    [Abstract] [Full Text] [Related]

  • 8. The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma.
    Skirnisdóttir I, Sorbe B, Seidal T.
    Int J Gynecol Cancer; 2001 Jan 02; 11(2):119-29. PubMed ID: 11328410
    [Abstract] [Full Text] [Related]

  • 9. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus.
    Ambros RA, Kurman RJ.
    Cancer; 1992 Mar 15; 69(6):1424-31. PubMed ID: 1371712
    [Abstract] [Full Text] [Related]

  • 10. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma.
    Bell JG, Minnick A, Reid GC, Judis J, Brownell M.
    Gynecol Oncol; 1997 Sep 15; 66(3):388-92. PubMed ID: 9299250
    [Abstract] [Full Text] [Related]

  • 11. Aromatase, cyclooxygenase 2, HER-2/neu, and p53 as prognostic factors in endometrioid endometrial cancer.
    Jongen VH, Briët JM, de Jong RA, Joppe E, ten Hoor KA, Boezen HM, Evans DB, Hollema H, van der Zee AG, Nijman HW.
    Int J Gynecol Cancer; 2009 May 15; 19(4):670-6. PubMed ID: 19509570
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors in surgical stage I endometrial carcinoma.
    Lundgren C, Auer G, Frankendal B, Nilsson B, Nordström B.
    Acta Oncol; 2004 May 15; 43(1):49-56. PubMed ID: 15068320
    [Abstract] [Full Text] [Related]

  • 13. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
    Reinartz JJ, George E, Lindgren BR, Niehans GA.
    Hum Pathol; 1994 Oct 15; 25(10):1075-83. PubMed ID: 7927313
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma.
    Hamel NW, Sebo TJ, Wilson TO, Keeney GL, Roche PC, Suman VJ, Hu TC, Podratz KC.
    Gynecol Oncol; 1996 Aug 15; 62(2):192-8. PubMed ID: 8751548
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J, Wen H, Bi R, Wu X.
    J Gynecol Oncol; 2016 Mar 15; 27(2):e18. PubMed ID: 26463439
    [Abstract] [Full Text] [Related]

  • 16. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B, Wu LY, Li SM, Zhang WH, Zhang R, Ma SK.
    Ai Zheng; 2004 Sep 15; 23(9):1085-8. PubMed ID: 15363208
    [Abstract] [Full Text] [Related]

  • 17. HER-2/neu expression: a major prognostic factor in endometrial cancer.
    Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS, Podratz KC.
    Gynecol Oncol; 1992 Nov 15; 47(2):179-85. PubMed ID: 1361478
    [Abstract] [Full Text] [Related]

  • 18. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
    Khalifa MA, Mannel RS, Haraway SD, Walker J, Min KW.
    Gynecol Oncol; 1994 Apr 15; 53(1):84-92. PubMed ID: 7909788
    [Abstract] [Full Text] [Related]

  • 19. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y, Yu M, Yang JX, Cao DY, Zhang Y, Shen K, You Y.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec 25; 53(12):816-822. PubMed ID: 30585019
    [Abstract] [Full Text] [Related]

  • 20. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP, Chin D, van Diest PJ, Ortiz R, Matze-Cok P, Bacus SS.
    Lab Invest; 1991 Feb 25; 64(2):215-23. PubMed ID: 1671789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.